Cytel Whitepaper on Increasing Development Productivity in Clinical Trials by 20%

Despite efforts to improve outcomes from clinical trials, the likelihood of success remains low. In the past decade, only one-third of Phase 3 clinical trials succeed. A new whitepaper from Cytel discusses a framework that provides increased productivity ranging from 10 to 20 percent.

“Innovative trial designs have the potential to improve probability of success, shorten trial durations, and reduce trial costs. Yet, Cytel’s recent research uncovered that traditional development team approaches to the end-to-end trial planning process make it difficult to fully consider the available statistical design options.” Read more here.

(Source: Cytel, 2021)